Nuwiq, Human cell line recombinant human factor VIII (Human-cl rhFVIII), 250IU, powder and solvent for solution for injection. Vial of powder and prefilled WFI syringe

Negara: Australia

Bahasa: Inggris

Sumber: Department of Health (Therapeutic Goods Administration)

Bahan aktif:

simoctocog alfa, Quantity: 250 IU

Tersedia dari:

Octapharma Australia Pty Ltd

INN (Nama Internasional):

simoctocog alfa

Bentuk farmasi:

Injection, powder for

Komposisi:

Excipient Ingredients: sucrose; sodium chloride; sodium citrate dihydrate; poloxamer; calcium chloride dihydrate; arginine hydrochloride

Rute administrasi :

Intravenous

Unit dalam paket:

1 vial

Jenis Resep:

exempt from scheduling - Appendix A; prescription medicine

Indikasi Terapi:

Treatment and prophylaxis of bleeding (also during and after surgery) in previously treated paediatric (>= 2 years) and adult patients with haemophilia A (congenital factor VIII deficiency). Nuwiq does not contain von Willebrand Factor and is thus not indicated to treat von Willebrand?s Disease.

Ringkasan produk:

Visual Identification: Nuwiq - white to off-white lyophilised powder,WFI - clear, colourless liquid; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 2 Years; Container Temperature: Store at 2 to 8 degrees Celsius

Status otorisasi:

Licence status A

Tanggal Otorisasi:

2014-11-10